nps-568 has been researched along with Hyperplasia in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (14.29) | 18.2507 |
| 2000's | 6 (85.71) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| de Vernejoul, MC; Legoupil, N; Ureña, P | 1 |
| Aguilera-Tejero, E; Almaden, Y; Cañadillas, S; Canalejo, A; Lopez, I; Martin, D; Rodriguez, M; Rodriguez, ME; Siendones, E | 1 |
| Akizawa, T; Hatamura, I; Kinugasa, E; Koiwa, F; Koshikawa, S; Mizobuchi, M; Ogata, H; Saji, F | 1 |
| Bennett, SA; Nemeth, EF | 1 |
| Chin, J; Fox, J; Furuya, Y; Nagano, N; Nemeth, EF; Wada, M | 1 |
| Chin, JI; Fox, J; Miller, SC; Nagano, N; Nemeth, EF; Wada, M | 1 |
| Goodman, WG | 1 |
3 review(s) available for nps-568 and Hyperplasia
| Article | Year |
|---|---|
[Calcimimetics, mechanisms of action and therapeutic applications].
Topics: Aniline Compounds; Animals; Bone Remodeling; Calcium; Cells, Cultured; Cinacalcet; Double-Blind Method; Female; Humans; Hyperparathyroidism; Hyperparathyroidism, Primary; Hyperparathyroidism, Secondary; Hyperplasia; Male; Middle Aged; Multicenter Studies as Topic; Naphthalenes; Parathyroid Glands; Parathyroid Hormone; Parathyroid Neoplasms; Phenethylamines; Propylamines; Randomized Controlled Trials as Topic; Rats; Receptors, Calcium-Sensing; Renal Dialysis; Risk Factors; Time Factors; Uremia | 2005 |
Tricking the parathyroid gland with novel calcimimetic agents.
Topics: Aniline Compounds; Animals; Calcitriol; Calcium; Humans; Hyperplasia; Parathyroid Glands; Parathyroid Hormone; Phenethylamines; Propylamines; Vitamin D | 1998 |
Calcimimetic agents and secondary hyperparathyroidism: treatment and prevention.
Topics: Aniline Compounds; Calcium; Clinical Trials as Topic; Humans; Hyperparathyroidism, Secondary; Hyperplasia; Parathyroid Glands; Phenethylamines; Propylamines | 2002 |
4 other study(ies) available for nps-568 and Hyperplasia
| Article | Year |
|---|---|
The calcimimetic R-568 increases vitamin D receptor expression in rat parathyroid glands.
Topics: Aniline Compounds; Animals; Calcitriol; Calcium; Dose-Response Relationship, Drug; Drug Combinations; Humans; Hyperparathyroidism; Hyperplasia; In Vitro Techniques; Male; Parathyroid Glands; Parathyroid Hormone; Phenethylamines; Propylamines; Rats; Rats, Wistar; Receptors, Calcitriol; RNA, Messenger | 2007 |
Activation of calcium-sensing receptor accelerates apoptosis in hyperplastic parathyroid cells.
Topics: Aniline Compounds; Animals; Apoptosis; Cyclodextrins; Hyperplasia; In Situ Nick-End Labeling; Male; Microscopy, Electron; Models, Biological; Parathyroid Glands; Phenethylamines; Propylamines; Rats; Rats, Sprague-Dawley; Receptors, Calcium-Sensing; Uremia | 2007 |
Calcimimetic NPS R-568 prevents parathyroid hyperplasia in rats with severe secondary hyperparathyroidism.
Topics: Aniline Compounds; Animals; Blood Urea Nitrogen; Body Weight; Calcium; Hyperparathyroidism, Secondary; Hyperplasia; Male; Parathyroid Diseases; Parathyroid Hormone; Phenethylamines; Propylamines; Rats; Rats, Sprague-Dawley | 2000 |
Activation of the calcium receptor by a calcimimetic compound halts the progression of secondary hyperparathyroidism in uremic rats.
Topics: Analysis of Variance; Aniline Compounds; Animals; Blood Urea Nitrogen; Calcium; Calcium-Binding Proteins; Creatinine; Hyperparathyroidism, Secondary; Hyperplasia; Parathyroid Glands; Parathyroid Hormone; Phenethylamines; Phosphates; Propylamines; Rats; Rats, Sprague-Dawley; Steroid Hydroxylases; Uremia | 2000 |